SCOR IN CORONARY AND VASCULAR DISEASES
冠状动脉和血管疾病中的 SCOR
基本信息
- 批准号:3106846
- 负责人:
- 金额:$ 129.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-01-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although research in atherosclerosis has focused on mechanisms of
initiation, relatively little attention has been given to the more pressing
problems of disease progression and recurrence after vascular
reconstruction. There are two major objectives in the SCOR: to develop an
understanding of how carotid atherosclerotic plaques enlarge and at a
certain point become the cause of thromboembolic events; and to explore
various aspects of the reparative response and the recurrence of lumenal
narrowing after endarterectomy. Four of the projects will examine
ultrasound characteristics of advanced atherosclerotic carotid and femoral
lesions and endarterectomy-induced intimal thickening. These will be
correlated with clinical symptoms and with the pathological characteristics
of the excised surgical specimens. In addition, these lesions will be
examined by in situ hybridization and Northern analysis for the expression
of specific genes important for smooth muscle growth.
Magnetic resonance imaging studies will be undertaken in vitro and in vivo
model systems to develop better methods for the morphological and
biochemical characterization of the human plaque. At the same time, animal
models of disease progression and recurrent stenosis will be developed to
define factors regulating smooth muscle proliferation and endothelial
regeneration. In addition to an Administrative Core, the SCOR will have
Morphology an Image Analysis Cores to provide histological,
immunocytological, and image procession support for the individual
projects.
The proposed studies will make use of a wide range of clinical basic
research approaches, including ultrasound, MRI, light and electron
microscopy, in situ hybridization, Norther analysis, analysis of cell cycle
kinetics and modern approaches to growth factor biochemistry.
尽管动脉粥样硬化的研究主要集中在
在开始时,相对较少关注更紧迫的问题,
血管内支架植入后的疾病进展和复发问题
重建 该委员会有两个主要目标:
了解颈动脉粥样硬化斑块如何扩大,
某些点成为血栓栓塞事件的原因;并探讨
修复反应和管腔复发的各个方面
动脉内膜切除术后狭窄。 其中四个项目将审查
晚期颈动脉和股动脉粥样硬化的超声特征
病变和动脉内膜切除术诱导的内膜增厚。 这些将是
与临床症状及病理特征相关
切除的手术标本 此外,这些病变将
通过原位杂交和北方分析检测表达
平滑肌生长的重要基因
磁共振成像研究将在体外和体内进行
模型系统,以开发更好的方法,
人斑块的生化表征。 与此同时,动物
将开发疾病进展和复发性狭窄的模型,
确定调节平滑肌增殖和内皮细胞增殖的因子
再生 除了行政核心外,SCOR还将拥有
形态学和 图像分析核心提供组织学,
免疫细胞学和图像处理支持的个人
项目
拟议的研究将利用广泛的临床基础
研究方法,包括超声波,MRI,光和电子
显微镜,原位杂交,Norther分析,细胞周期分析
动力学和生长因子生物化学的现代方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD E STRANDNESS其他文献
DONALD E STRANDNESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD E STRANDNESS', 18)}}的其他基金
QUANTIFICATION OF FACTORS LEADING TO VEIN GRAFT FAILURE
导致静脉移植失败的因素的量化
- 批准号:
2029148 - 财政年份:1996
- 资助金额:
$ 129.76万 - 项目类别:
QUANTIFICATION OF FACTORS LEADING TO VEIN GRAFT FAILURE
导致静脉移植失败的因素的量化
- 批准号:
2750416 - 财政年份:1996
- 资助金额:
$ 129.76万 - 项目类别:
QUANTIFICATION OF FACTORS LEADING TO VEIN GRAFT FAILURE
导致静脉移植失败的因素的量化
- 批准号:
6043825 - 财政年份:1996
- 资助金额:
$ 129.76万 - 项目类别:
QUANTIFICATION OF FACTORS LEADING TO VEIN GRAFT FAILURE
导致静脉移植失败的因素的量化
- 批准号:
2460048 - 财政年份:1996
- 资助金额:
$ 129.76万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 129.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 129.76万 - 项目类别: